Possible new target for treatment of multiple sclerosis found – Medical Xpress

March 23, 2017 Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

In the relentless battle against multiple sclerosis (MS), U of A researchers recently discovered an entirely new cellular mechanisman underlying defect in brain cellsthat may to be blame for the disease, and a potential hallmark that may be a target for future treatment.

The finding opens the door to a brand new avenue of study in the battle against the cryptic autoimmune disorder that strikes more Canadians than any other nationality worldwide, said Fabrizio Giuliani, study co-author, U of A neurologist and medical director of the Northern Alberta MS Clinic.

"Scientists have been pointing to the mitochondria, the powerhouse of the cell, as a possible link to MS, but have not been able to decipher how they malfunction. Ours is the first study that combines clinical and lab experiments to explain how mitochondria become defective in MS patients," said Thomas Simmen, study co-author and cell biology professor.

Specifically, using human brain tissue samples, the researchers discovered how two sub-components within a cell are miscommunicating in patients with MS, and identified how at least one protein (Rab32) is swooping in to trigger the dangerous dysfunction.

"A part of the cell that stores calcium (ER or endoplasmic reticulum) gets too close to the part of the cell that creates energy (mitochondria) when massive amounts of Rab32 are present in the brain of MS patients. The resulting miscommunication with the calcium supply triggers the mitochondria to misbehave, ultimately causing toxicity for brain cells in MS patients," explained Simmen.

In healthy brain tissue samples, there's virtually no Rab32 present, he added.

Researchers don't know why or what causes an unwelcome influx of Rab32 but they theorize the defect could originate at the base of the ER.

With this finding in hand, not only can scientists search for effective treatments that target Rab32, added Simmen, they can embark on determining whether there are other proteins that may be at play.

"Rab32 is just one of the proteins that is having the effect of drawing the ER and mitochondria too close. There are dozens of other possibilities," he said.

This discovery may give hope to the 100,000 Canadians living with MS who have had to rely on partially effective treatments that aim to reduce inflammation, and, sometimes, controversial experiential treatments such as the vein-widening treatment.

The study, conducted with researchers at the University of Exeter, was recently published in the Journal of Neuroinflammation.

Explore further: Getting closer to treatment for Parkinson's

More information: Yohannes Haile et al, Rab32 connects ER stress to mitochondrial defects in multiple sclerosis, Journal of Neuroinflammation (2017). DOI: 10.1186/s12974-016-0788-z

More than 10 million people worldwide have Parkinson's disease. The cause of Parkinson's disease is unknown and thus no effective treatments exist. A study from the University of Bergen (UiB) suggests that the secret of the ...

UCLA researchers have discovered the molecular basis of, and identified potential treatment for, an incurable disease known as inclusion body myopathy, Paget disease with frontotemporal dementia, or IBMPFD. Using both genetically ...

A fault with the natural waste disposal system that helps to keep our brain cell 'batteries' healthy may contribute to neurodegenerative disease, a new study has found.

Cell powerhouses are typically long and lean, but with brain injury such as stroke or trauma, they can quickly become bloated and dysfunctional, say scientists who documented the phenomena in real time for the first time ...

Scientists at The Wistar Institute have identified a novel protein pathway across several types of cancer that controls how tumor cells acquire the energy necessary for movement, invasion and metastasis. This protein pathway ...

One third of patients with anxiety disorders do not respond to currently available anxiolytic treatments. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have shown for the first time ...

In the relentless battle against multiple sclerosis (MS), U of A researchers recently discovered an entirely new cellular mechanisman underlying defect in brain cellsthat may to be blame for the disease, and a potential ...

Improved treatments for people with severe asthma are a 'step closer' after a research team led by the University of Leicester identified a breakthrough in the cause of airway narrowing.

Numerous human diseases, including inflammatory bowel disease, diabetes and autism spectrum disorders have been linked to abnormal gut microbial communities, or microbiomes, but an open question is whether these altered microbiomes ...

Researchers at the UNC School of Medicine believe they have isolated a protein that, when missing or depleted, can cause airway constriction, production of mucus, chest tightness, and difficulty breathing for the 334 million ...

Taking certain omega-3 fatty acid supplements during pregnancy can reduce the risk of childhood asthma by almost one third, according to a new study from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) ...

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. It is commonly treated with one of several available biological drugs that block an ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

The rest is here:
Possible new target for treatment of multiple sclerosis found - Medical Xpress